Literature DB >> 28259250

Evolution of the registration regulations for proprietary Chinese medicines in China.

Lin Yuan1, Zhi-Ang Wu2, Ming-Li Shao3.   

Abstract

In this review, we provide a comprehensive overview on the registration of proprietary Chinese medicines (PCMs) in China over the past century by examining published literature and historical data. We will examine this evolving administrative practice for PCMs registration in China, which is divided to the following five stages: (1) initial measures (1915-1948); (2) early development (1949-1965); (3) provincial approval and trial implementation of the "approval number" system (1966-1984); (4) legislation and cleanup (1985-1999); and (5) centralized national approval (2000 until now), offering a panoramic view on the characteristics of PCMs registration management in China.
Copyright © 2017 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Keywords:  China; Proprietary Chinese Medicine; Registration

Mesh:

Substances:

Year:  2017        PMID: 28259250     DOI: 10.1016/S1875-5364(17)30003-1

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  2 in total

1.  Microorganism Determination of 10 Proprietary Chinese Medicines for Children by Plate Culture or Membrane Filtration.

Authors:  Hong Cai; Danchun Jia; Yuan Ke
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-18       Impact factor: 2.650

2.  Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems.

Authors:  Chenglai Xia; Dongning Yao; Yunfeng Lai; Yan Xue; Hao Hu
Journal:  Chin Med       Date:  2022-01-04       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.